This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hyundai Pharm Co., Ltd.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Heeil Chae: Innovator in Pharmaceutical Composition
Introduction
Heeil Chae is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes in the human body. His work is characterized by a focus on enhancing the efficacy and solubility of pharmaceutical compositions.
Latest Patents
Heeil Chae holds a patent for a compound aimed at inhibiting 11β-hydroxy steroid dehydrogenase 1. The patent describes a novel compound or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition that includes this compound. This invention is particularly noteworthy for its excellent activity and solubility, making it more efficient in formulation and transfer.
Career Highlights
Chae's career is marked by his dedication to research and innovation in the pharmaceutical industry. He is currently associated with Hyundai Pharm Co., Ltd., where he continues to develop groundbreaking solutions that address critical health issues. His work has the potential to impact the treatment of various conditions related to steroid metabolism.
Collaborations
Heeil Chae collaborates with talented colleagues, including Inhee Lee and Sehoan Kim. These partnerships enhance the research environment and foster innovation within their projects.
Conclusion
Heeil Chae's contributions to pharmaceutical innovation demonstrate his commitment to advancing medical science. His patent for a compound that inhibits 11β-hydroxy steroid dehydrogenase 1 showcases his ability to create effective solutions in the field.